Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial

نویسندگان

  • Mark B. Zimering
  • Jeffrey Knight
  • Ling Ge
  • Gideon Bahn
  • Jeremy Soule
  • Susan Caulder
  • Clare Pittman
  • Omayra Alston
  • Ronald K. Mayfield
  • Greg Moffitt
  • Julius Sagel
  • Frank Sanacor
  • Elizabeth Ganaway
  • Jennifer Marks
  • Lorraine Okur
  • Lucille Jones
  • Hermes Florez
  • Donna Pfeifer
  • Luis Samos
  • Andrew L. Taylor
  • Mark B. Zimering
  • Adilia Sama
  • Frances Rosenberg
  • Heidi Garcia
  • Norman Ertel
  • Leonard Pogach
  • J. Shin John
  • Felice Caldarella
  • Constantino Carseli
  • Mamta Shah
  • Paulette Ginier
  • George Arakel
  • Yangheng Fu
  • Don Tayloe
  • Jack E. Allen
  • Elizabeth Fox
  • Paula G. Hensley
  • Nicholas Emanuele
  • Kathleen Kahsen
  • Patricia Linnerud
  • Lily Agrawal
  • Nasrin Azad
  • Marco Marcelli
  • Glenn R. Cunningham
  • Natalie M. Nichols
  • Emilia Cordero
  • Rabih Hijazi
  • Farid Roman
  • Paromita Datta
  • Mariana Garcia Touza
  • Amale Lteif
  • Karen L. Moore
  • Christina Lazar-Robinson
  • Sanjay Gupta
  • M. Sue Kirkman
  • Martha Mendez
  • Zehra Haider
  • Lora Risley
  • Dennis Karounos
  • Linda Barber
  • Janet Hibbard
  • James W. Anderson
  • L. Raymond Reynolds
  • Jeff Carlsen
  • Robert W. Collins
  • As’ad Ehtisham
  • Moti L. Kashyap
  • Barbara Matheus
  • Tina Rahbarnia
  • Anthony N. Vo
  • Nancy Downey
  • Lynette Fox
  • Richard M. Gonzales
  • C. Daniel Meyers
  • Subramaniam Tavintharan
  • Frank Q. Nuttall
  • Lisa Cupersmith
  • Kathy Dardick
  • Linda Kollman
  • Angeliki Georgopoulos
  • Catherine Niewoehner
  • Stephen N. Davis
  • Paula Harper
  • Diana Davis
  • Jessica Devin
  • Annis Marney
  • Julia Passyn-Dunn
  • Jennifer Perkins
  • John Stafford
  • Al Powers
  • Linda Balch
  • Patricia Harris
  • Robert J. Anderson
  • Diana Dunning
  • Steve Ludwig
  • Marlene Vogel
  • Cyrus DeSouza
  • Robert Ecklund
  • Sarah Doran
  • Claire Korolchuk
  • Mary McElmeel
  • Sarah Wagstaff
  • Peter Reaven
  • Bradley Solie
  • John Matchette
  • Christian Meyer
  • Sylvia Vela
  • Nadeem Aslam
  • Eliot Brinton
  • Joy Clark
  • Alisa Domb
  • Linda McDonald
  • Lynae Shurtz
  • R. Harsha Rao
  • Janice N. Beattie
  • Carol Franko
  • Frederick R. DeRubertis
  • David Kelly
  • Melisse Maser
  • Juleen Paul
  • Franklin Zieve
  • Susan J. Clark
  • Ann Grimsdale
  • Sonja Fredrickson
  • James Levy
  • Diane Schroeder
  • Ali Iranmanesh
  • Barbara Dunn
  • Donna Arsura
  • Csaba Kovesdy
  • Suzanne Hanna
  • Ashraf Iranmanesh
  • Christy Florow
  • Fe Remandaban
  • Erica Smith
  • Robert R. Henry
  • Miriam Keller
  • Vanita Aroda
  • Charles Choe
  • Steven Edelman
  • Andrea Gasper
  • Dereck MaFong
  • Sunder Mudaliar
  • Deborah Oh
  • Rahil Bandukwala
  • Anna Chang
  • Sandeep Chaudhary
  • Sithophol Chinnapongse
  • Louie Christiansen
  • Neelima Chu
  • Dennis Kim
  • Mark Lupo
  • Manju Chandra
  • Ray Plodkowski
  • Roopa Sathyaprakash
  • Janet Wilson
  • Joseph Yu
  • Gina Macaraeg
  • Shelley Townes
  • Ralph DeFronzo
  • Lisa Johnson
  • Ken Cusi
  • Devjit Tripathy
  • Mandeep Bajaj
  • Janet Blodgett
  • Sangeeta Kayshup
  • Mary Helen Vasquez
  • Barbara Walz
  • Tess Weaver
  • Julio Benabe
  • Zuleika Mercado
  • Brunilda Padilla
  • Jocelyn Serrano-Rodriguez
  • Carlos Rosado
  • Edwin Mejias
  • Tania Tejera
  • Clorinda Geldrez
  • Elda Gonzalez-Melendez
  • Maria Natal
  • Jimenez Maribel Rios
  • Jayendra H. Shah
  • Wendy S. Wendel
  • Lynnette Scott
  • Lynne A. Gurnsey
  • Fabia A. Kwiecinski
  • Thomas Boyden
  • Merilyn G. Goldschmidt
  • Virginia Easton
چکیده

AIMS Cognitive decline disproportionately affects older adult type 2 diabetes. We tested whether randomized intensive (INT) glucose-lowering reduces the rate(s) of cognitive decline in adults with advanced type 2 diabetes (mean: age, 60 years; diabetes duration, 11 years) from the Veterans Affairs Diabetes Trial. METHODS A battery of neuropsychological tests [digit span, digit symbol substitution (DSym), and Trails-making Test-Part B (TMT-B)] was administered at baseline in ~1700 participants and repeated at year 5. Thirty-seven risk factors were evaluated as predictors of cognitive decline in multivariable regression analyses. RESULTS The mean age-adjusted DSym or TMT-B declined significantly in all study participants (P < 0.001). Randomized INT glucose-lowering did not significantly alter the rate of cognitive decline. The final model of risk factors associated with 5-year decline in age-adjusted TMT-B included as significant predictors: longer baseline diabetes duration (beta = -0.028; P = 0.0057), lower baseline diastolic blood pressure (BP; beta = 0.028; P = 0.002), and baseline calcium channel blocker medication use (beta = -0.639; P < 0.001). Higher baseline pulse pressure was significantly associated with decline in age-adjusted TMT-B suggesting a role for both higher systolic and lower diastolic BPs. Baseline thiazide diuretic use (beta = -0.549; P = 0.015) was an additional significant predictor of 5-year decline in age-adjusted digit symbol score. Post-baseline systolic BP-lowering was significantly associated (P < 0.001) with decline in TMT-B performance. There was a significant inverse association between post-baseline plasma triglyceride-lowering (P = 0.045) and decline in digit symbol substitution task performance. CONCLUSION A 5-year period of randomized INT glucose-lowering did not significantly reduce the rate of cognitive decline in older-aged adults with type 2 diabetes. Systolic and diastolic BPs as well as plasma triglycerides appeared as modifiable risk factors of the rate of cognitive decline in older adult type 2 diabetes.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Basic Fibroblast Growth Factor Predicts Cardiovascular Disease Occurrence in Participants from the Veterans Affairs Diabetes Trial

AIM Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in adults with type 2 diabetes mellitus. The aim of the present study was to test whether plasma basic fibroblast growth factor (bFGF) levels predict future CVD occurrence in adults from the Veterans Affairs Diabetes Trial (VADT). METHODS Nearly 400 veterans, 40 years of age or older having a mean baseline diabetes...

متن کامل

Relationship Between Caregiver Burden and Cognitive Impairment in Adult Patients with Type 2 Diabetes

Introduction: Caregivers play a critical role in health management of patients with chronic diseases. Caregiving is associated with experiencing different emotional and psychological problems. Objective: This study aims to determine the relationship between caregiver burden and cognitive function in adult patients with Type 2 Diabetes (T2D). Materials and Methods: In this cross-sectional stud...

متن کامل

Alterations in adult hippocampal neurogenesis, aberrant protein s-nitrosylation, and associated spatial memory loss in streptozotocin-induced diabetes mellitus type 2 mice

Objective(s): Epidemiological and biochemical studies conducted over the past two decades have established a strong link between type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD). However, the exact mechanisms through which aberrations in insulin signaling associated with T2DM contribute to cognitive decline are not yet known. Materials and Methods: In an effort to explore possible m...

متن کامل

Tight Glycemic Control and Use of Hypoglycemic Medications in Older Veterans With Type 2 Diabetes and Comorbid Dementia

OBJECTIVE Older adults with diabetes and dementia are at increased risk for hypoglycemia and other adverse events associated with tight glycemic control and are unlikely to experience long-term benefits. We examined risk factors for tight glycemic control in this population and use of medications associated with a high risk of hypoglycemia in the subset with tight control. RESEARCH DESIGN AND...

متن کامل

Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)

OBJECTIVE To determine the predictors of progression of calcified atherosclerosis and the effect of intensive glycemic control on this process in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS As part of the Risk Factors, Atherosclerosis, and Clinical Events in Diabetes (RACED) substudy of the Veterans Affairs Diabetes Trial (VADT), 197 and 189 individuals with type 2 diabetes rec...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 7  شماره 

صفحات  -

تاریخ انتشار 2016